Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Income from Continuing Operations: 2009-2019

Historic Income from Continuing Operations for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $37.0 million.

  • Neurocrine Biosciences' Income from Continuing Operations rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.3 million, marking a year-over-year decrease of 57.93%. This contributed to the annual value of $37.0 million for FY2019, which is 75.32% up from last year.
  • According to the latest figures from FY2019, Neurocrine Biosciences' Income from Continuing Operations is $37.0 million, which was up 75.32% from $21.1 million recorded in FY2018.
  • Neurocrine Biosciences' 5-year Income from Continuing Operations high stood at $37.0 million for FY2019, and its period low was -$142.5 million during FY2017.
  • Over the past 3 years, Neurocrine Biosciences' median Income from Continuing Operations value was $21.1 million (recorded in 2018), while the average stood at -$28.1 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first slumped by 52.90% in 2016, then soared by 114.81% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Income from Continuing Operations (Yearly) stood at -$92.3 million in 2015, then slumped by 52.90% to -$141.1 million in 2016, then dropped by 1.03% to -$142.5 million in 2017, then soared by 114.81% to $21.1 million in 2018, then surged by 75.32% to $37.0 million in 2019.